Candidate Sulfonated and Sulfated Topical Microbicides: Comparison of Anti-Human Immunodeficiency Virus Activities and Mechanisms of Action
Open Access
- 1 September 2005
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 49 (9) , 3607-3615
- https://doi.org/10.1128/aac.49.9.3607-3615.2005
Abstract
Poly(styrene 4-sulfonate), cellulose sulfate, polymethylenehydroquinone, and PRO 2000 are sulfated or sulfonated polymers (SPs) under development as topical microbicides. They are presumed to work through similar mechanisms of action, although to date there has been no extensive comparison of their anti-human immunodeficiency virus activities. To determine whether any of these candidate microbicides offers a potential advantage, their in vitro activities, mechanisms of action, stabilities in biological secretions, and toxicities were compared. All four compounds were found to be active against X4, R5, and dualtropic primary isolates and against X4 and R5 laboratory-adapted strains in CD4 + T cells, macrophages, and single-coreceptor cell lines. Our single-cycle experiments using pseudotyped virus suggest that all four SPs function at the binding and entry stages of the viral life cycle but differ in degree of postentry effect. Surface plasmon resonance analyses demonstrate that SPs bind to X4 and R5 monomeric glycoprotein 120 with similar high binding affinities. When mixed with cervicovaginal lavage fluid, SPs maintain inhibitory activity at concentrations achievable in formulations.Keywords
This publication has 26 references indexed in Scilit:
- In Vitro Comparison of Topical Microbicides for Prevention of Human Immunodeficiency Virus Type 1 TransmissionAntimicrobial Agents and Chemotherapy, 2004
- Candidate Topical Microbicides Bind Herpes Simplex Virus Glycoprotein B and Prevent Viral Entry and Cell-to-Cell SpreadAntimicrobial Agents and Chemotherapy, 2004
- Mouse Model of Cervicovaginal Toxicity and Inflammation for Preclinical Evaluation of Topical Vaginal MicrobicidesAntimicrobial Agents and Chemotherapy, 2004
- Blockade of Attachment and Fusion Receptors Inhibits HIV-1 Infection of Human Cervical TissueThe Journal of Experimental Medicine, 2004
- Mandelic Acid Condensation Polymer: Novel Candidate Microbicide for Prevention of Human Immunodeficiency Virus and Herpes Simplex Virus EntryJournal of Virology, 2002
- Preliminary safety and acceptability of a carrageenan gel for possible use as a vaginal microbicideSexually Transmitted Infections, 2000
- A phase I study of a novel potential intravaginal microbicide, PRO 2000, in healthy sexually inactive womenSexually Transmitted Infections, 2000
- Anti-HIV Type 1 Activity of Sulfated Derivatives of Dextrin against Primary Viral Isolates of HIV Type 1 in Lymphocytes and Monocyte-Derived MacrophagesAIDS Research and Human Retroviruses, 1997
- The World Health Organization Global Programme on AIDS Proposal for Standardization of HIV Sequence NomenclatureAIDS Research and Human Retroviruses, 1994
- INACTIVATION OF HTLV-III/LAV-INFECTED CULTURES OF NORMAL HUMAN LYMPHOCYTES BY NONOXYNOL-9 IN VITROThe Lancet, 1985